Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Management of Aortic Dissection with Beta Blockers

Introduction to Beta Blocker Therapy

  • The American College of Cardiology recommends beta blockers as the preferred first-line antihypertensive agents for aortic dissection because they reduce both blood pressure and the force of left ventricular ejection, directly decreasing the shear stress on the aortic wall 1, 2, 3

The Fundamental Mechanism: Reducing Aortic Wall Stress

  • Beta blockers reduce the force of left ventricular ejection, which directly decreases the mechanical stress that propagates the dissection and weakens the arterial wall, as recommended by the European Heart Journal 4, 5
  • Calcium channel blockers only reduce blood pressure through vasodilation but do not address the force of ventricular contraction, and when used alone, may paradoxically increase the force of ventricular contraction through reflex sympathetic activation, according to the European Heart Journal 4, 5

Guideline Recommendations

  • The American College of Cardiology and American Heart Association provide a Class I, Level C-EO recommendation that beta blockers are the preferred antihypertensive agents in patients with thoracic aortic disease, including both acute and chronic aortic dissection 1, 2, 3, 6, 7
  • The European Heart Journal guidelines recommend intravenous beta blockers as first-line therapy to reduce systolic blood pressure to 100-120 mmHg 4, 5

Evidence Supporting Beta Blocker Superiority

  • In both Type A and Type B aortic dissections, beta blockers were associated with improved survival, whereas ACE inhibitors did not improve survival, as reported in the Journal of the American College of Cardiology 1, 2, 3, 7
  • Observational studies demonstrate a lower risk for operative repair with beta-blocker therapy in patients with chronic aortic dissection, according to the Journal of the American College of Cardiology 1, 2, 3, 7

Clinical Algorithm for Drug Selection

  • The European Heart Journal recommends starting immediately with intravenous beta blockers, with a target heart rate ≤60 beats per minute and systolic blood pressure 100-120 mmHg 4, 5
  • Esmolol is the preferred beta blocker due to its short half-life, allowing for rapid titration, as recommended by the European Heart Journal 4, 5

Important Clinical Pitfalls

  • The most dangerous error is administering vasodilators without prior beta blockade, as this can increase the force of ventricular ejection and propagate the dissection, according to the European Heart Journal 4, 5
  • Abrupt discontinuation of beta blockers in patients with aortic disease can precipitate acute dissection, as documented in case reports, although the citation for this specific fact is not provided, the overall recommendation is supported by 1, 2

REFERENCES